166 related articles for article (PubMed ID: 10611137)
1. Glucuronidation of thyroxine in primary monolayer cultures of rat hepatocytes: in vitro induction of UDP-glucuronosyltranferases by methylcholanthrene, clofibrate, and dexamethasone alone and in combination.
Jemnitz K; Veres Z; Monostory K; Vereczkey L
Drug Metab Dispos; 2000 Jan; 28(1):34-7. PubMed ID: 10611137
[TBL] [Abstract][Full Text] [Related]
2. Coordinate regulation of UDP-glucuronosyltransferase UGT1A6 induction by 3-methylcholanthrene and multidrug resistance protein MRP2 expression by dexamethasone in primary rat hepatocytes.
Jemnitz K; Veres Z; Vereczkey L
Biochem Pharmacol; 2002 Jun; 63(12):2137-44. PubMed ID: 12110372
[TBL] [Abstract][Full Text] [Related]
3. Glucuronidation of thyroid hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions.
Visser TJ; Kaptein E; van Toor H; van Raaij JA; van den Berg KJ; Joe CT; van Engelen JG; Brouwer A
Endocrinology; 1993 Nov; 133(5):2177-86. PubMed ID: 8404669
[TBL] [Abstract][Full Text] [Related]
4. Developmental aspects of glucocorticoid regulation of polycyclic aromatic hydrocarbon-inducible enzymes in rat liver.
Linder MW; Prough RA
Arch Biochem Biophys; 1993 Apr; 302(1):92-102. PubMed ID: 8470911
[TBL] [Abstract][Full Text] [Related]
5. Distribution and inducibility by 3-methylcholanthrene of family 1 UDP-glucuronosyltransferases in the rat gastrointestinal tract.
Grams B; Harms A; Braun S; Strassburg CP; Manns MP; Obermayer-Straub P
Arch Biochem Biophys; 2000 May; 377(2):255-65. PubMed ID: 10845702
[TBL] [Abstract][Full Text] [Related]
6. Male rat hepatic UDP-glucuronosyltransferase activity toward thyroxine. Activation and induction properties--relation with thyroxine plasma disappearance rate.
de Sandro V; Catinot R; Kriszt W; Cordier A; Richert L
Biochem Pharmacol; 1992 Apr; 43(7):1563-9. PubMed ID: 1567478
[TBL] [Abstract][Full Text] [Related]
7. In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases.
Tong Z; Li H; Goljer I; McConnell O; Chandrasekaran A
Drug Metab Dispos; 2007 Dec; 35(12):2203-10. PubMed ID: 17875670
[TBL] [Abstract][Full Text] [Related]
8. Mono- and diglucuronide formation from chrysene and benzo(a)pyrene phenols by 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase (UGT1A1).
Bock KW; Gschaidmeier H; Seidel A; Baird S; Burchell B
Mol Pharmacol; 1992 Oct; 42(4):613-8. PubMed ID: 1435739
[TBL] [Abstract][Full Text] [Related]
9. Induction of UDP-glucuronosyltransferase activities in Gunn, heterozygous, and Wistar rat livers by pregnenolone-16 alpha-carbonitrile.
Watkins JB; Klaassen CD
Drug Metab Dispos; 1982; 10(6):590-4. PubMed ID: 6130905
[TBL] [Abstract][Full Text] [Related]
10. Clofibrate increases hepatic triiodothyronine (T3)- and thyroxine (T4)-glucuronosyltransferase activities and lowers plasma T3 and T4 concentrations in pigs.
Luci S; Kluge H; Hirche F; Eder K
Drug Metab Dispos; 2006 Nov; 34(11):1887-92. PubMed ID: 16896063
[TBL] [Abstract][Full Text] [Related]
11. In vitro induction of bilirubin conjugation in primary rat hepatocyte culture.
Jemnitz K; Lengyel G; Vereczkey L
Biochem Biophys Res Commun; 2002 Feb; 291(1):29-33. PubMed ID: 11829457
[TBL] [Abstract][Full Text] [Related]
12. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
[TBL] [Abstract][Full Text] [Related]
13. Increase in rat liver UDP-glucuronosyltransferase mRNA by microsomal enzyme inducers that enhance thyroid hormone glucuronidation.
Vansell NR; Klaassen CD
Drug Metab Dispos; 2002 Mar; 30(3):240-6. PubMed ID: 11854140
[TBL] [Abstract][Full Text] [Related]
14. Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study.
Liu J; Liu Y; Barter RA; Klaassen CD
J Pharmacol Exp Ther; 1995 May; 273(2):977-85. PubMed ID: 7752103
[TBL] [Abstract][Full Text] [Related]
15. Increased biliary excretion of thyroxine by microsomal enzyme inducers.
Vansell NR; Klaassen CD
Toxicol Appl Pharmacol; 2001 Nov; 176(3):187-94. PubMed ID: 11714251
[TBL] [Abstract][Full Text] [Related]
16. UDP-glucuronosyltransferase activity toward digitoxigenin-monodigitoxoside. Differences in activation and induction properties in rat and mouse liver.
Hazelton GA; Klaassen CD
Drug Metab Dispos; 1988; 16(1):30-6. PubMed ID: 2894952
[TBL] [Abstract][Full Text] [Related]
17. Hepatocytes cultured in alginate microspheres: an optimized technique to study enzyme induction.
Ringel M; von Mach MA; Santos R; Feilen PJ; Brulport M; Hermes M; Bauer AW; Schormann W; Tanner B; Schön MR; Oesch F; Hengstler JG
Toxicology; 2005 Jan; 206(1):153-67. PubMed ID: 15590115
[TBL] [Abstract][Full Text] [Related]
18. Phenobarbital, beta-naphthoflavone, clofibrate, and pregnenolone-16alpha-carbonitrile do not affect hepatic thyroid hormone UDP-glucuronosyl transferase activity, and thyroid gland function in mice.
Viollon-Abadie C; Lassere D; Debruyne E; Nicod L; Carmichael N; Richert L
Toxicol Appl Pharmacol; 1999 Feb; 155(1):1-12. PubMed ID: 10036213
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effect of inducers on the expression of glutathione-S-transferases in the liver of the intact rat and in hepatocytes in primary culture.
Langouët S; Morel F; Meyer DJ; Fardel O; Corcos L; Ketterer B; Guillouzo A
Hepatology; 1996 Apr; 23(4):881-7. PubMed ID: 8666345
[TBL] [Abstract][Full Text] [Related]
20. Drug metabolizing enzyme expression in rat choroid plexus: effects of in vivo xenobiotics treatment.
Gradinaru D; Minn AL; Artur Y; Minn A; Heydel JM
Arch Toxicol; 2009 Jun; 83(6):581-6. PubMed ID: 19023562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]